Nuvelo Begins Phase II Trial Of Thrombolytic For Ischemic Stroke
This article was originally published in The Pink Sheet Daily
Executive Summary
After poor Phase III results for catheter occlusion and loss of Bayer partnership, company cites optimism about efficacy in stroke.